Daniel van den Bergh(49)
Kaiser Permanente Ventures Principal
location
Oakland, California
investment range
$5.0m - $16.0m
sweet spot
$8.0m
most interested in
Enterprise healthcare IT, digital health, healthcare services, medical technologynot interested in
KP Ventures does not invest: - in drug development (biotech) - outside of the US - in businesses that would compete with parts of Kaiser Permanente (Medicare Advantage plans, for example)Daniel van den Bergh's Past Investments (10)
| Company | Deal Type | Amount | Date | |
|---|---|---|---|---|
| Nuvolo | Series B | $12M (Lead) | Jul 2019 | |
| NextHealth Technologies | Series B | $20M | Mar 2019 | |
| Collective Medical Technologies | Series A | $47.5M | Nov 2017 | |
| Protenus | Series A | $7M (Lead) | Jul 2017 | |
| QuantiaMD | Series E | $12M | Aug 2013 | |
| Sotera Wireless | Series D1 | $15M | May 2013 | |
| Prognos | Series B | $15M | May 2013 | |
| NuPathe | PIPE | $28M | Oct 2012 | |
| Putney Vet | Series C | $21M (Lead) | Sep 2011 | |
| Advanced Biohealing | Acquisition | $750M | May 2011 |
Daniel van den Bergh's Education
The Wharton School MBA Healthcare and entrepreneurship
Cornell University BS Biological Engineering
Daniel van den Bergh's Media
No media found for Daniel van den Bergh.